Global Mono Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Mono Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 105

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

According to our (Global Info Research) latest study, the global Mono Hepatitis A Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Mono Hepatitis A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Mono Hepatitis A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mono Hepatitis A Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mono Hepatitis A Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac and Zhejiang Pukang, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Mono Hepatitis A Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Market segment by Application
Government Institution
Private Sector
Other

Major players covered
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mono Hepatitis A Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mono Hepatitis A Vaccine, with price, sales, revenue and global market share of Mono Hepatitis A Vaccine from 2018 to 2023.
Chapter 3, the Mono Hepatitis A Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mono Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Mono Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mono Hepatitis A Vaccine.
Chapter 14 and 15, to describe Mono Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Mono Hepatitis A Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mono Hepatitis A Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Inactivated Vaccine
1.3.3 Live Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Mono Hepatitis A Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global Mono Hepatitis A Vaccine Market Size & Forecast
1.5.1 Global Mono Hepatitis A Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Mono Hepatitis A Vaccine Sales Quantity (2018-2029)
1.5.3 Global Mono Hepatitis A Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mono Hepatitis A Vaccine Product and Services
2.1.4 GSK Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Mono Hepatitis A Vaccine Product and Services
2.2.4 Merck Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Mono Hepatitis A Vaccine Product and Services
2.3.4 Sanofi Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Mono Hepatitis A Vaccine Product and Services
2.4.4 Sinovac Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sinovac Recent Developments/Updates
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Product and Services
2.5.4 Zhejiang Pukang Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Pukang Recent Developments/Updates
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Product and Services
2.6.4 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Changchun Institute of Biological Recent Developments/Updates
2.7 Kaketsuken
2.7.1 Kaketsuken Details
2.7.2 Kaketsuken Major Business
2.7.3 Kaketsuken Mono Hepatitis A Vaccine Product and Services
2.7.4 Kaketsuken Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Kaketsuken Recent Developments/Updates
2.8 IMBCA
2.8.1 IMBCA Details
2.8.2 IMBCA Major Business
2.8.3 IMBCA Mono Hepatitis A Vaccine Product and Services
2.8.4 IMBCA Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 IMBCA Recent Developments/Updates
2.9 ChangSheng
2.9.1 ChangSheng Details
2.9.2 ChangSheng Major Business
2.9.3 ChangSheng Mono Hepatitis A Vaccine Product and Services
2.9.4 ChangSheng Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ChangSheng Recent Developments/Updates
2.10 Convac
2.10.1 Convac Details
2.10.2 Convac Major Business
2.10.3 Convac Mono Hepatitis A Vaccine Product and Services
2.10.4 Convac Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Convac Recent Developments/Updates

3 Competitive Environment: Mono Hepatitis A Vaccine by Manufacturer
3.1 Global Mono Hepatitis A Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Mono Hepatitis A Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Mono Hepatitis A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Mono Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Mono Hepatitis A Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Mono Hepatitis A Vaccine Manufacturer Market Share in 2022
3.5 Mono Hepatitis A Vaccine Market: Overall Company Footprint Analysis
3.5.1 Mono Hepatitis A Vaccine Market: Region Footprint
3.5.2 Mono Hepatitis A Vaccine Market: Company Product Type Footprint
3.5.3 Mono Hepatitis A Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Mono Hepatitis A Vaccine Market Size by Region
4.1.1 Global Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Mono Hepatitis A Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Mono Hepatitis A Vaccine Average Price by Region (2018-2029)
4.2 North America Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.3 Europe Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.5 South America Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Mono Hepatitis A Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Mono Hepatitis A Vaccine Consumption Value by Type (2018-2029)
5.3 Global Mono Hepatitis A Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Mono Hepatitis A Vaccine Consumption Value by Application (2018-2029)
6.3 Global Mono Hepatitis A Vaccine Average Price by Application (2018-2029)

7 North America
7.1 North America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Mono Hepatitis A Vaccine Market Size by Country
7.3.1 North America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Mono Hepatitis A Vaccine Market Size by Country
8.3.1 Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Mono Hepatitis A Vaccine Market Size by Region
9.3.1 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Mono Hepatitis A Vaccine Market Size by Country
10.3.1 South America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Mono Hepatitis A Vaccine Market Size by Country
11.3.1 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Mono Hepatitis A Vaccine Market Drivers
12.2 Mono Hepatitis A Vaccine Market Restraints
12.3 Mono Hepatitis A Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Mono Hepatitis A Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mono Hepatitis A Vaccine
13.3 Mono Hepatitis A Vaccine Production Process
13.4 Mono Hepatitis A Vaccine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mono Hepatitis A Vaccine Typical Distributors
14.3 Mono Hepatitis A Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Mono Hepatitis A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Mono Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Mono Hepatitis A Vaccine Product and Services
Table 6. GSK Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GSK Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Mono Hepatitis A Vaccine Product and Services
Table 11. Merck Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Mono Hepatitis A Vaccine Product and Services
Table 16. Sanofi Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Sinovac Basic Information, Manufacturing Base and Competitors
Table 19. Sinovac Major Business
Table 20. Sinovac Mono Hepatitis A Vaccine Product and Services
Table 21. Sinovac Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sinovac Recent Developments/Updates
Table 23. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Pukang Major Business
Table 25. Zhejiang Pukang Mono Hepatitis A Vaccine Product and Services
Table 26. Zhejiang Pukang Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Pukang Recent Developments/Updates
Table 28. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 29. Changchun Institute of Biological Major Business
Table 30. Changchun Institute of Biological Mono Hepatitis A Vaccine Product and Services
Table 31. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Changchun Institute of Biological Recent Developments/Updates
Table 33. Kaketsuken Basic Information, Manufacturing Base and Competitors
Table 34. Kaketsuken Major Business
Table 35. Kaketsuken Mono Hepatitis A Vaccine Product and Services
Table 36. Kaketsuken Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Kaketsuken Recent Developments/Updates
Table 38. IMBCA Basic Information, Manufacturing Base and Competitors
Table 39. IMBCA Major Business
Table 40. IMBCA Mono Hepatitis A Vaccine Product and Services
Table 41. IMBCA Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. IMBCA Recent Developments/Updates
Table 43. ChangSheng Basic Information, Manufacturing Base and Competitors
Table 44. ChangSheng Major Business
Table 45. ChangSheng Mono Hepatitis A Vaccine Product and Services
Table 46. ChangSheng Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. ChangSheng Recent Developments/Updates
Table 48. Convac Basic Information, Manufacturing Base and Competitors
Table 49. Convac Major Business
Table 50. Convac Mono Hepatitis A Vaccine Product and Services
Table 51. Convac Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Convac Recent Developments/Updates
Table 53. Global Mono Hepatitis A Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Mono Hepatitis A Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Mono Hepatitis A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Mono Hepatitis A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Mono Hepatitis A Vaccine Production Site of Key Manufacturer
Table 58. Mono Hepatitis A Vaccine Market: Company Product Type Footprint
Table 59. Mono Hepatitis A Vaccine Market: Company Product Application Footprint
Table 60. Mono Hepatitis A Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Mono Hepatitis A Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Mono Hepatitis A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Mono Hepatitis A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Mono Hepatitis A Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Mono Hepatitis A Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Mono Hepatitis A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Mono Hepatitis A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Mono Hepatitis A Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Mono Hepatitis A Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Mono Hepatitis A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Mono Hepatitis A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Mono Hepatitis A Vaccine Raw Material
Table 121. Key Manufacturers of Mono Hepatitis A Vaccine Raw Materials
Table 122. Mono Hepatitis A Vaccine Typical Distributors
Table 123. Mono Hepatitis A Vaccine Typical Customers
List of Figures
Figure 1. Mono Hepatitis A Vaccine Picture
Figure 2. Global Mono Hepatitis A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Inactivated Vaccine Examples
Figure 5. Live Attenuated Vaccine Examples
Figure 6. Global Mono Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Government Institution Examples
Figure 9. Private Sector Examples
Figure 10. Other Examples
Figure 11. Global Mono Hepatitis A Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Mono Hepatitis A Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Mono Hepatitis A Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Mono Hepatitis A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Mono Hepatitis A Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Mono Hepatitis A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Mono Hepatitis A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Mono Hepatitis A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Mono Hepatitis A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Mono Hepatitis A Vaccine Market Drivers
Figure 74. Mono Hepatitis A Vaccine Market Restraints
Figure 75. Mono Hepatitis A Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Mono Hepatitis A Vaccine
Figure 79. Mono Hepatitis A Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Mono Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Mono Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 105

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

According to our (Global Info Research) latest study, the global Mono Hepatitis A Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Mono Hepatitis A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Mono Hepatitis A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Mono Hepatitis A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mono Hepatitis A Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mono Hepatitis A Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac and Zhejiang Pukang, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Mono Hepatitis A Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Market segment by Application
Government Institution
Private Sector
Other

Major players covered
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mono Hepatitis A Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mono Hepatitis A Vaccine, with price, sales, revenue and global market share of Mono Hepatitis A Vaccine from 2018 to 2023.
Chapter 3, the Mono Hepatitis A Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mono Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Mono Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mono Hepatitis A Vaccine.
Chapter 14 and 15, to describe Mono Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Mono Hepatitis A Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mono Hepatitis A Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Inactivated Vaccine
1.3.3 Live Attenuated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Mono Hepatitis A Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Government Institution
1.4.3 Private Sector
1.4.4 Other
1.5 Global Mono Hepatitis A Vaccine Market Size & Forecast
1.5.1 Global Mono Hepatitis A Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Mono Hepatitis A Vaccine Sales Quantity (2018-2029)
1.5.3 Global Mono Hepatitis A Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mono Hepatitis A Vaccine Product and Services
2.1.4 GSK Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GSK Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Mono Hepatitis A Vaccine Product and Services
2.2.4 Merck Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Mono Hepatitis A Vaccine Product and Services
2.3.4 Sanofi Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Sinovac
2.4.1 Sinovac Details
2.4.2 Sinovac Major Business
2.4.3 Sinovac Mono Hepatitis A Vaccine Product and Services
2.4.4 Sinovac Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sinovac Recent Developments/Updates
2.5 Zhejiang Pukang
2.5.1 Zhejiang Pukang Details
2.5.2 Zhejiang Pukang Major Business
2.5.3 Zhejiang Pukang Mono Hepatitis A Vaccine Product and Services
2.5.4 Zhejiang Pukang Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Pukang Recent Developments/Updates
2.6 Changchun Institute of Biological
2.6.1 Changchun Institute of Biological Details
2.6.2 Changchun Institute of Biological Major Business
2.6.3 Changchun Institute of Biological Mono Hepatitis A Vaccine Product and Services
2.6.4 Changchun Institute of Biological Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Changchun Institute of Biological Recent Developments/Updates
2.7 Kaketsuken
2.7.1 Kaketsuken Details
2.7.2 Kaketsuken Major Business
2.7.3 Kaketsuken Mono Hepatitis A Vaccine Product and Services
2.7.4 Kaketsuken Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Kaketsuken Recent Developments/Updates
2.8 IMBCA
2.8.1 IMBCA Details
2.8.2 IMBCA Major Business
2.8.3 IMBCA Mono Hepatitis A Vaccine Product and Services
2.8.4 IMBCA Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 IMBCA Recent Developments/Updates
2.9 ChangSheng
2.9.1 ChangSheng Details
2.9.2 ChangSheng Major Business
2.9.3 ChangSheng Mono Hepatitis A Vaccine Product and Services
2.9.4 ChangSheng Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 ChangSheng Recent Developments/Updates
2.10 Convac
2.10.1 Convac Details
2.10.2 Convac Major Business
2.10.3 Convac Mono Hepatitis A Vaccine Product and Services
2.10.4 Convac Mono Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Convac Recent Developments/Updates

3 Competitive Environment: Mono Hepatitis A Vaccine by Manufacturer
3.1 Global Mono Hepatitis A Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Mono Hepatitis A Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Mono Hepatitis A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Mono Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Mono Hepatitis A Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Mono Hepatitis A Vaccine Manufacturer Market Share in 2022
3.5 Mono Hepatitis A Vaccine Market: Overall Company Footprint Analysis
3.5.1 Mono Hepatitis A Vaccine Market: Region Footprint
3.5.2 Mono Hepatitis A Vaccine Market: Company Product Type Footprint
3.5.3 Mono Hepatitis A Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Mono Hepatitis A Vaccine Market Size by Region
4.1.1 Global Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Mono Hepatitis A Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Mono Hepatitis A Vaccine Average Price by Region (2018-2029)
4.2 North America Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.3 Europe Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.5 South America Mono Hepatitis A Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Mono Hepatitis A Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Mono Hepatitis A Vaccine Consumption Value by Type (2018-2029)
5.3 Global Mono Hepatitis A Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Mono Hepatitis A Vaccine Consumption Value by Application (2018-2029)
6.3 Global Mono Hepatitis A Vaccine Average Price by Application (2018-2029)

7 North America
7.1 North America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Mono Hepatitis A Vaccine Market Size by Country
7.3.1 North America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Mono Hepatitis A Vaccine Market Size by Country
8.3.1 Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Mono Hepatitis A Vaccine Market Size by Region
9.3.1 Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Mono Hepatitis A Vaccine Market Size by Country
10.3.1 South America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Mono Hepatitis A Vaccine Market Size by Country
11.3.1 Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Mono Hepatitis A Vaccine Market Drivers
12.2 Mono Hepatitis A Vaccine Market Restraints
12.3 Mono Hepatitis A Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Mono Hepatitis A Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mono Hepatitis A Vaccine
13.3 Mono Hepatitis A Vaccine Production Process
13.4 Mono Hepatitis A Vaccine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mono Hepatitis A Vaccine Typical Distributors
14.3 Mono Hepatitis A Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Mono Hepatitis A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Mono Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Mono Hepatitis A Vaccine Product and Services
Table 6. GSK Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GSK Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Mono Hepatitis A Vaccine Product and Services
Table 11. Merck Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi Mono Hepatitis A Vaccine Product and Services
Table 16. Sanofi Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Sinovac Basic Information, Manufacturing Base and Competitors
Table 19. Sinovac Major Business
Table 20. Sinovac Mono Hepatitis A Vaccine Product and Services
Table 21. Sinovac Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sinovac Recent Developments/Updates
Table 23. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Pukang Major Business
Table 25. Zhejiang Pukang Mono Hepatitis A Vaccine Product and Services
Table 26. Zhejiang Pukang Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Pukang Recent Developments/Updates
Table 28. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 29. Changchun Institute of Biological Major Business
Table 30. Changchun Institute of Biological Mono Hepatitis A Vaccine Product and Services
Table 31. Changchun Institute of Biological Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Changchun Institute of Biological Recent Developments/Updates
Table 33. Kaketsuken Basic Information, Manufacturing Base and Competitors
Table 34. Kaketsuken Major Business
Table 35. Kaketsuken Mono Hepatitis A Vaccine Product and Services
Table 36. Kaketsuken Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Kaketsuken Recent Developments/Updates
Table 38. IMBCA Basic Information, Manufacturing Base and Competitors
Table 39. IMBCA Major Business
Table 40. IMBCA Mono Hepatitis A Vaccine Product and Services
Table 41. IMBCA Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. IMBCA Recent Developments/Updates
Table 43. ChangSheng Basic Information, Manufacturing Base and Competitors
Table 44. ChangSheng Major Business
Table 45. ChangSheng Mono Hepatitis A Vaccine Product and Services
Table 46. ChangSheng Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. ChangSheng Recent Developments/Updates
Table 48. Convac Basic Information, Manufacturing Base and Competitors
Table 49. Convac Major Business
Table 50. Convac Mono Hepatitis A Vaccine Product and Services
Table 51. Convac Mono Hepatitis A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Convac Recent Developments/Updates
Table 53. Global Mono Hepatitis A Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Mono Hepatitis A Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Mono Hepatitis A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Mono Hepatitis A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Mono Hepatitis A Vaccine Production Site of Key Manufacturer
Table 58. Mono Hepatitis A Vaccine Market: Company Product Type Footprint
Table 59. Mono Hepatitis A Vaccine Market: Company Product Application Footprint
Table 60. Mono Hepatitis A Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Mono Hepatitis A Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Mono Hepatitis A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Mono Hepatitis A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Mono Hepatitis A Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Mono Hepatitis A Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Mono Hepatitis A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Mono Hepatitis A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Mono Hepatitis A Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Mono Hepatitis A Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Mono Hepatitis A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Mono Hepatitis A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Mono Hepatitis A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Mono Hepatitis A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Mono Hepatitis A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Mono Hepatitis A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Mono Hepatitis A Vaccine Raw Material
Table 121. Key Manufacturers of Mono Hepatitis A Vaccine Raw Materials
Table 122. Mono Hepatitis A Vaccine Typical Distributors
Table 123. Mono Hepatitis A Vaccine Typical Customers
List of Figures
Figure 1. Mono Hepatitis A Vaccine Picture
Figure 2. Global Mono Hepatitis A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Inactivated Vaccine Examples
Figure 5. Live Attenuated Vaccine Examples
Figure 6. Global Mono Hepatitis A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Government Institution Examples
Figure 9. Private Sector Examples
Figure 10. Other Examples
Figure 11. Global Mono Hepatitis A Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Mono Hepatitis A Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Mono Hepatitis A Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Mono Hepatitis A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Mono Hepatitis A Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Mono Hepatitis A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Mono Hepatitis A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Mono Hepatitis A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Mono Hepatitis A Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Mono Hepatitis A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Mono Hepatitis A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Mono Hepatitis A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Mono Hepatitis A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Mono Hepatitis A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Mono Hepatitis A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Mono Hepatitis A Vaccine Market Drivers
Figure 74. Mono Hepatitis A Vaccine Market Restraints
Figure 75. Mono Hepatitis A Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Mono Hepatitis A Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Mono Hepatitis A Vaccine
Figure 79. Mono Hepatitis A Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
jiaGou

Add To Cart

gouMai

Buy Now